PMDA — authorised 23 March 2021
- Marketing authorisation holder: Eisai Co., Ltd.
- Status: approved
PMDA authorised Ontak on 23 March 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 March 2021.
Eisai Co., Ltd. holds the Japanese marketing authorisation.